Cargando…
How Did We Get Here: The Best Vaccines Ever Facing the Highest Public Hesitancy?
mRNA vaccine technology is the most interesting final product of decades of research. This new platform for public health is simple to transfer to low-income countries and can be used against diverse agents, including cancer. It is environmentally clean, relatively low-cost, and does not use animals...
Autor principal: | Ferreccio, Catterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458189/ https://www.ncbi.nlm.nih.gov/pubmed/37631891 http://dx.doi.org/10.3390/vaccines11081323 |
Ejemplares similares
-
Retinal Research in Latin America: How Did We Get Here?
por: AREVALO, J. Fernando
Publicado: (2017) -
Treatment of Gliomas: How did we get here?
por: Chowdhary, Michelle M., et al.
Publicado: (2015) -
How did we get here? Thoughts on health care system drivers of pediatric radiology burnout
por: Taylor, George A., et al.
Publicado: (2022) -
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?
por: Siri-Angkul, Natthaphat, et al.
Publicado: (2021) -
“How Did We Get Here?”: Topic Drift in Online Health Discussions
por: Park, Albert, et al.
Publicado: (2016)